As his center wins comprehensive (again), Carlos Arteaga tells us how NCI’s standards have evolved

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

NCI has renewed the Harold C. Simmons Comprehensive Cancer Center’s comprehensive designation.

“I think this is special, because I think it is a marker of an evolution of the institution, which has always been a basic science powerhouse, and now is enhancing an increasingly outstanding enterprise in translational cancer research and cancer care, community outreach and engagement, and education and training in cancer,” Carlos L. Arteaga, director of the Simmons Cancer Center at UT Southwestern, said to The Cancer Letter.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Paul Goldberg
Editor & Publisher
Table of Contents

YOU MAY BE INTERESTED IN

“I don’t know of a single grant that left my desk that was not approved and funded,” NCI Director Anthony G. Letai said on this episode of The Cancer Letter Podcast. https://open.spotify.com/episode/2PFYGwliBDYEbxBXFd9MtB?si=95DNBAy0QGSKBX31_uETEA This episode is available on Spotify, Apple Podcasts, and Youtube. Letai recapped his first year as NCI director in conversation with Paul Goldberg,...

A year ago, when he was sworn in as director of the National Cancer Institute, Anthony G. Letai set a goal: Reassure cancer researchers that the institute will keep a steady course aimed at finding treatments for cancer.
Paul Goldberg
Editor & Publisher

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login